Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The introduction of the subcutaneous formulation contributed to Entyvio maintaining its position as the leading treatment in the inflammatory bowel disease (IBD) market in the US
Cardiovascular Benefits: GLP-1s have shown cardiovascular protective effects, reducing risk of heart attack and stroke in people with type 2 diabetes 4
Electrical neuroimaging based on biophysical constraints
Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma
US$ 27.32
US$ 25.71
US$ 28.97
US$ 26.13
US$ 27.69
US$ 20.06
US$ 28.28
